Next Article in Journal
Morbid Obesity in Disasters: Bringing the “Conspicuously Invisible” into Focus
Previous Article in Journal
Multi-Level, Multi-Component Approaches to Community Based Interventions for Healthy Living—A Three Case Comparison
Article

Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection

1
Department of Infectious Disease, the Jurong People’s Hospital, Jurong 212400, China
2
Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Paul B. Tchounwou
Int. J. Environ. Res. Public Health 2016, 13(10), 1030; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph13101030
Received: 28 July 2016 / Revised: 29 September 2016 / Accepted: 13 October 2016 / Published: 20 October 2016
Background: HLA-DM gene, which is related to antigen processing and presentation and located in the non-classical class-II region of human leukocyte antigen (HLA) region, may play a crucial role in chronic hepatitis C virus (HCV) infection treatment outcomes. The study was conducted to evaluate the role of the variant of several single nucleotide polymorphisms (SNPs) in HLA-DM gene in HCV treatment outcomes. Methods: We genotyped four SNPs from the candidate genes (HLA-DMA and DMB) in 336 patients who were treated with pegylated interferon-alpha and ribavirin (PEG IFN-α/RBV). Multivariate analysis of factors predicting sustained virological response (SVR) was conducted. Results: HLA-DMA rs1063478 and DMB rs23544 were independent factors of HCV treatment outcomes in Chinese Han population. Individuals who carried favorable genotypes of rs1063478TT and rs23544GG were more likely to achieve SVR {Dominant model: odds ratio (OR) = 2.05, 95% confidence interval (CI) = 1.24–3.41; OR = 2.04, 95% CI =1.23–3.35, respectively}. Rs23544, rs1063478, baseline glucose, baseline platelet and T4 level were independent predictors of SVR. The area under the receiver operating characteristic (ROC) curve (AUC) was 0.740. Conclusions: The genetic variation of rs1063478 and rs23544 are associated with the treatment outcomes in the Chinese Han population. View Full-Text
Keywords: hepatitis C; genetic polymorphism; HLA-DM gene; treatment outcome hepatitis C; genetic polymorphism; HLA-DM gene; treatment outcome
Show Figures

Figure 1

MDPI and ACS Style

Chen, H.; Yao, Y.; Wang, Y.; Zhou, H.; Xu, T.; Liu, J.; Wang, G.; Zhang, Y.; Chen, X.; Liu, Q.; Huang, P.; Yu, R. Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection. Int. J. Environ. Res. Public Health 2016, 13, 1030. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph13101030

AMA Style

Chen H, Yao Y, Wang Y, Zhou H, Xu T, Liu J, Wang G, Zhang Y, Chen X, Liu Q, Huang P, Yu R. Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection. International Journal of Environmental Research and Public Health. 2016; 13(10):1030. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph13101030

Chicago/Turabian Style

Chen, Hongbo, Yinan Yao, Yifan Wang, Hua Zhou, Tianxiang Xu, Jing Liu, Guocheng Wang, Yongfeng Zhang, Xiang Chen, Qingwei Liu, Peng Huang, and Rongbin Yu. 2016. "Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection" International Journal of Environmental Research and Public Health 13, no. 10: 1030. https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph13101030

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop